Book a Meeting to See How Hospitals are Making Glycemic Care Safer
To get started, please complete the form and a Glytec specialist will be in touch to schedule a meeting.
400+
hospital clients
100+
patents
16 years
of innovation
50B+
data points
FDA-cleared
Glucommander®
What We’ll Cover
Each live Demo will cover the four pillars of GlytecOne, with time for Q&A from your team.
Care Enablement
How FDA-cleared Glucommander® provides algorithm-based IV and SubQ insulin dosing guidance at the point of care. Clinicians review and confirm all recommendations.
Decision Support
How Command Center organizes and displays current and historical patient glucose data to support clinician awareness, structured clinical review, and care coordination.
Performance Insights
How enterprise dashboards and CQM-aligned reporting through Command Center help your quality and leadership teams baseline, benchmark, and track glycemic performance.
Population Health
How enterprise-wide glycemic intelligence aids health system leaders and health plan partners across the entire health system.
Why Hospitals Are Acting Now
CMS Is Measuring Glycemic Safety
CMS now requires hospitals to report severe hypoglycemia (NQF #3503e) and severe hyperglycemia (NQF #3533e) as hospital harm eCQMs. The 2026 measurement period is active. Hospitals that do not report risk forfeiting the full 2.6% annual Medicare reimbursement increase.
Manual Protocols Create Avoidable Risk
Protocol compliance with manual workflows averages below 60%. Variability across units, shifts, and providers leaves clinicians without the consistent, validated support needed for safe insulin management.
Peer Institutions Are Modernizing
More than 400 hospitals already use GlytecOne and FDA-cleared Glucommander® for safer, more consistent glycemic management. As CMS glycemic safety metrics become publicly visible, the gap between organizations that have adopted proactive approaches and those that have not will become measurable.